Goldline Pharmaceutical IPO Date, Review, Price, Allotment Details
Goldline Pharmaceutical IPO is offering its shares to the public for the first time through an IPO on the stock exchanges BSE SME. The total amount they aim to raise is 27,00,000 shares (agg. up to ₹12 Cr). Out of this 25,62,000 shares (agg. up to ₹11 Cr) will be through new shares, and [.] through existing shares. The IPO is open for subscription from 12 May, 2026 to 14 May, 2026. Each share has a face value of Rs 10, and investors can apply for shares at a price between ₹41 to ₹43 per share. The minimum number of shares one can apply for is 3000, or multiples of that as mentioned in the offer document.
|
Check Live IPO GMP List 👈
|
|
Check Live IPO Subscription List 👈
|
|
Check All IPO Allotment List 👈
|
| Upcoming |
Goldline Pharmaceutical IPO Details
| IPO Category Type: | SME |
| IPO Open: | 12 May, 2026 |
| IPO Close: | 14 May, 2026 |
| IPO Price Band: | ₹41 to ₹43 per share |
| Face Value: | ₹10 Per Equity Share |
| IPO Listing on: | BSE SME |
| IPO Issue Type: | Book Build Issue |
| IPO Size: | Approx 27,00,000 shares (agg. up to ₹12 Cr) |
| Fresh Issue: | Approx 25,62,000 shares (agg. up to ₹11 Cr) |
| Offer for Sale: | Approx [.] |
Goldline Pharmaceutical IPO Reservation
| Retail Quota: | 33.33% |
| QIB Quota: | 47.11% |
| NII Quota: | 14.44% |
| Employee Discount: | [.] |
Goldline Pharmaceutical IPO Prospectus
| DRHP Draft Prospectus: | [.] |
| RHP Draft Prospectus: | Continue Reading |
| Anchor Investors List: | [.] |
Goldline Pharmaceutical IPO Market Lot Details
| Application | Lot Size | Shares | Amount |
|---|---|---|---|
| 1 | 3000 | ₹129000 |
| Application | Lot Size | Shares | Amount |
|---|---|---|---|
| Individual investors (Retail) (Min) | 2 | 6,000 | 258000 |
| Individual investors (Retail) (Max) | 2 | 6,000 | 258000 |
| S-HNI (Min) | 3 | 9,000 | 387000 |
| S-HNI (Max) | 7 | 21,000 | 903000 |
| B-HNI (Min) | 8 | 24,000 | 1032000 |
Goldline Pharmaceutical IPO Dates
| IPO Activity | Date |
|---|---|
| Open Date: | 12 May, 2026 |
| Close Date: | 14 May, 2026 |
| Allotment Date: | 15 May, 2026 |
| Refund Date: | 18 May, 2026 |
| Shares Credit Date: | 18 May, 2026 |
| Listing Date: | 19 May, 2026 |
Goldline Pharmaceutical Company Financial Report
| Period Ended | 31 Dec 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | 27.40 | 26.28 | 22.93 | 19.39 |
| Total Income | 21.41 | 28.06 | 23.57 | 19.85 |
| Profit After Tax | 2.22 | 2.83 | 1.81 | 0.26 |
| EBITDA | 4.16 | 5.83 | 4.30 | 2.19 |
| NET Worth | 12.36 | 10.35 | 7.86 | 5.89 |
| Reserves and Surplus | 3.65 | 1.65 | 3.76 | 2.08 |
| Total Borrowing | 9.47 | 11.03 | 11.13 | 10.83 |
| Amount in ₹ Crore | ||||
Goldline Pharmaceutical Company Address
| Company | Goldline Pharmaceutical Ltd. |
|---|---|
| Address | 103, F-1, Leela Apartment, Shilpa HSG Society,Near Saptagiri Nagar, Shanidham,Narendra Nagar,, Nagpur, Maharashtra, 440015 |
| Phone | +91 712 2786666 |
| info@goldlinepharma.in | |
| Website | https://www.goldlinepharma.in/ |
Goldline Pharmaceutical IPO Registrar
| Company | Bigshare Services Pvt.Ltd. |
|---|---|
| Phone | +91-22-6263 8200 |
| ipo@bigshareonline.com | |
| Website | https://ipo.bigshareonline.com/IPO_Status.html |
Goldline Pharmaceutical IPO Lead Manager
- Cumulative Capital Pvt.Ltd.
Goldline Pharmaceutical IPO KPI
| KPI | Values |
|---|---|
| ROE | 21.02% |
| ROCE | 24.22% |
| Debt/Equity | 1.07 |
| RoNW | 17.99% |
| PAT Margin | 10.38% |
| EBITDA Margin | 19.41% |
Goldline Pharmaceutical IPO - FAQs
Q.What is Goldline Pharmaceutical IPO?
Ans.Goldline Pharmaceutical IPO is a SME IPO. The IPO is list on BSE SME. The total amount Goldline Pharmaceutical aim to raise is 27,00,000 shares (agg. up to ₹12 Cr).
Q.When Goldline Pharmaceutical IPO will open?
Ans.Goldline Pharmaceutical IPO is to open on 12 May, 2026 for Investors.
Q.What is Goldline Pharmaceutical IPO Investors Portion?
Ans.Goldline Pharmaceutical investor's portion for QIB is 47.11%, NII is 14.44%, and Retail is 33.33%.
Q.What is Goldline Pharmaceutical IPO Size?
Ans.Goldline Pharmaceutical IPO size is 27,00,000 shares (agg. up to ₹12 Cr).
Q.What is Goldline Pharmaceutical IPO Price Band?
Ans.Goldline Pharmaceutical IPO Price Band is ₹41 to ₹43 per share.
Q.What is the Goldline Pharmaceutical IPO Allotment Date?
Ans.Goldline Pharmaceutical IPO allotment date is 15 May, 2026.
Q.What is the Goldline Pharmaceutical IPO Listing Date?
Ans.Goldline Pharmaceutical IPO listing date is 19 May, 2026. The IPO is to list on BSE SME.